The Group is committed to ensuring that equal opportunities are provided to all employees and potential employees, and do not discriminate on the basis of age, gender, ethnicity, religion, disability, sexual orientation or marital status. All employees are expected to conduct themselves in an appropriate manner adhering to our non-discrimination policy.
In all aspects of our business the Group looks to act in ways that are compliant with the necessary laws and regulations, providing our employees with a work environment that is professional, ethical and fair.
As with all businesses the emphasis on environmental sustainability is of the utmost importance and is subject to increasing scrutiny and regulation. It is the responsibility of all employees to follow the initiatives implemented to decrease our carbon footprint, energy consumption and environmental sustainability efforts.
During 2020, the Group continued to implement environmental sustainability initiatives:
- Continued to upgrade to LED lighting alternatives in our offices, clean rooms and sterile packaging areas
- Switched to plastic bins rather than cardboard boxes in our WIP storage area which will reduce our cardboard waste
- Replacement of our air compressor and drying unit with a smaller, more efficient unit which is expected to reduce this energy consumption by c.70%
- In our facility expansion, the design included energy saving LED lighting with self-dimming or motion sensors throughout the facility, higher efficiency heating and cooling units, and greater use of solid flooring versus carpeting. Regarding equipment, we will be implementing high efficiency ultra-low temperature freezers which use natural refrigerants
Corporate social responsibility ("CSR")
Operating in a highly regulated environment, with particular sensitivities and responsibilities around human donor processing, the Group ensures to operate with a high level of CSR across the business every day. Through the gift of tissue donation we have the ability to positively impact hundreds of patients’ lives, therefore, we must treat each gift with the utmost respect and provide the next of kin with information around how many patients the donation has helped, if requested; something that can often help in the grieving process.
Health and safety
We see the development and maintenance of a robust health and safety framework as a necessity in order to protect our employees, customers, suppliers and external stakeholders. The Board reviews a health and safety report as part of the monthly Board pack, which contains information on any near miss events, accidents, incidents and preventative measures implemented. During 2020, no serious adverse events were experienced.
Improved patient care and health economic outcomes
Tissue Regenix technology platforms dCELL® and BioRinse®, process products that can enable improvements in patient care, enhancing or restoring their quality of life, which can often be transformative.
On top of this, it allows for economic advantages in the cost of care by reducing the hospital stay or additional treatments, better clinical outcomes and minimised rehabilitation - in some orthopaedic cases - a reduction in reoccurring operations, and in many circumstances, a reduction in associated pain.
Engagement and communication
The Group endeavours to undertake engagement and communications with all stakeholder groups whether they are employees, investors, partners, suppliers, customers, donor families or key opinion leaders, and considers how the day-to-day activities of the Group, and the principal decisions taken throughout the year, could affect each stakeholder group.
The Group has an established vision, mission, values and behaviours that form an integral part of the Tissue Regenix Group ethos and culture.
During 2020, the Group also looked to improve its communication and engagement with retail investors by allowing participation in the equity fundraise through a PrimaryBid offering and undertaking Company presentations through the investor meet platform.